AnaptysBio Stock (NASDAQ:ANAB), Quotes and News Summary

Q: What sector and industry does AnaptysBio (ANAB) operate in?

AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

AnaptysBio Stock (NASDAQ: ANAB) stock price, news, charts, stock research, profile.

Open	$19.610
Close	-
Volume / Avg.	176.470K / 325.897K
Day Range	19.080 - 20.660
52 Wk Range	13.360 - 27.500
Market Cap	$521.880M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	23.57%
Days to Cover	10.28

Recent News

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Avi Kapoor

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.

Avi Kapoor

Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers

AnaptysBio exceeds Q4 2023 earnings expectations, with sales of $9.01 million. Expectations high post-Wedbush upgrade, foreseeing stock surge amid clinical milestones. Analysis compares PD-1 agonist progress against Eli Lilly

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About AnaptysBio Inc

Sector

Health Care

Industry

Biotechnology

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antib...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy AnaptysBio (ANAB) stock?

You can purchase shares of AnaptysBio (NASDAQ: ANAB) through any online brokerage.

View our list of the best stock brokerages.

Who are AnaptysBio's (ANAB) competitors?

Other companies in AnaptysBio’s space includes: Skye Bioscience (NASDAQ:SKYE), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).

What is the target price for AnaptysBio (ANAB) stock?

The latest price target for AnaptysBio (NASDAQ: ANAB) was reported by Leerink Partners on Tuesday, April 16, 2024. The analyst firm set a price target for 47.00 expecting ANAB to rise to within 12 months (a possible 138.46% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for AnaptysBio (ANAB)?

The stock price for AnaptysBio (NASDAQ: ANAB) is $19.71 last updated Today at April 19, 2024 at 9:29 AM EDT.

Does AnaptysBio (ANAB) pay a dividend?

There are no upcoming dividends for AnaptysBio.

When is AnaptysBio (NASDAQ:ANAB) reporting earnings?

AnaptysBio’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is AnaptysBio (ANAB) going to split?

There is no upcoming split for AnaptysBio.

What sector and industry does AnaptysBio (ANAB) operate in?

AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-